Loncar China Biopharma ETF (CHNA) Short Interest Ratio & Short Volume → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free CHNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Loncar China Biopharma ETF Short Interest DataCurrent Short Volume500 sharesPrevious Short Volume500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$7,180.00Short Interest Ratio / Days to Cover0.5Last Record DateSeptember 30, 2022Outstanding Shares1,430,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume100 sharesAverage Trading Volume538 sharesToday's Volume Vs. Average19% Short Selling Loncar China Biopharma ETF ? Sign up to receive the latest short interest report for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCHNA Short Interest Over TimeCHNA Days to Cover Over TimeCHNA Percentage of Float Shorted Over Time Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Loncar China Biopharma ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/2022500 shares $7,180.00 No ChangeN/A0.5 $14.36 9/15/2022500 shares $8,020.00 -16.7%N/A0.3 $16.04 8/31/2022600 shares $10,662.00 No ChangeN/A0.3 $17.77 8/15/2022600 shares $11,061.60 -40.0%N/A0.3 $18.44 7/31/20221,000 shares $18,710.00 -82.1%N/A0.6 $18.71 7/15/20225,600 shares $110,320.00 No ChangeN/A2 $19.70 Get the Latest News and Ratings for CHNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter. 11/30/2021500 shares $16,670.00 -54.6%N/A0.2 $33.34 11/15/20211,100 shares $37,191.00 +120.0%N/A0.4 $33.81 10/29/2021500 shares $16,697.50 -54.6%N/A0.2 $33.40 10/15/20211,100 shares $38,874.11 No ChangeN/A0.4 $35.34 9/30/20211,100 shares $41,019.00 No ChangeN/A0.3 $37.29 9/15/20211,100 shares $42,729.28 -21.4%N/A0.2 $38.84 8/31/20211,400 shares $53,018.00 -22.2%N/A0.3 $37.87 8/13/20211,800 shares $72,414.00 -40.0%N/A0.3 $40.23 7/30/20213,000 shares $124,770.00 -31.8%N/A0.6 $41.59 7/15/20214,400 shares $200,772.00 +10.0%N/A0.7 $45.63 6/30/20214,000 shares $190,160.00 +110.5%N/A0.8 $47.54 6/15/20211,900 shares $85,747.00 -24.0%N/A0.5 $45.13 5/28/20212,500 shares $112,675.00 +316.7%N/A0.7 $45.07 5/14/2021600 shares $23,895.54 -80.0%N/A0.2 $39.83 4/30/20213,000 shares $124,170.00 +100.0%N/A0.7 $41.39 4/15/20211,500 shares $55,561.50 +200.0%N/A0.3 $37.04 3/31/2021500 shares $18,328.45 -76.2%N/A0.1 $36.66 3/15/20212,100 shares $76,251.00 -43.2%N/A0.4 $36.31 2/26/20213,700 shares $140,315.10 -80.0%N/A0.6 $37.92 2/12/202118,500 shares $754,060.00 +270.0%N/A3.4 $40.76 1/29/20215,000 shares $181,775.00 +4,900.0%N/A1.1 $36.36 1/15/2021100 shares $3,510.38 No ChangeN/A0 $35.10 9/15/2020500 shares $15,561.55 +150.0%N/A0.1 $31.12 8/31/2020200 shares $6,336.00 -75.0%N/A0 $31.68 8/14/2020800 shares $25,440.00 +60.0%N/A0.2 $31.80 7/31/2020500 shares $16,022.50 -73.7%N/A0.1 $32.05 7/15/20201,900 shares $63,194.00 -20.8%N/A0.3 $33.26 6/30/20202,400 shares $73,416.00 +2,300.0%N/A0.4 $30.59 6/15/2020100 shares $2,832.00 No ChangeN/A0 $28.32 5/29/2020100 shares $2,584.00 -50.0%N/A0 $25.84 5/15/2020200 shares $5,256.00 -77.8%N/A0 $26.28 4/30/2020900 shares $23,103.00 No ChangeN/A0.1 $25.67 4/15/2020900 shares $22,032.00 +800.0%N/A0.1 $24.48 3/31/2020100 shares $2,271.00 -96.9%N/A0 $22.71Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. CHNA Short Interest - Frequently Asked Questions What is Loncar China Biopharma ETF's current short interest? Short interest is the volume of Loncar China Biopharma ETF shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 500 shares of CHNA short. Learn More on Loncar China Biopharma ETF's current short interest. How does Loncar China Biopharma ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Loncar China Biopharma ETF: ProShares UltraShort Nasdaq Biotechnology (7.88%), JPMorgan Healthcare Leaders ETF (0.08%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), Invesco Nasdaq Biotechnology ETF (1.75%), Principal Healthcare Innovators ETF (0.29%), ProShares Ultra Nasdaq Biotechnology (2.28%), Invesco S&P SmallCap Health Care ETF (0.03%), VanEck Biotech ETF (0.09%), VanEck Pharmaceutical ETF (24.39%), and iShares Biotechnology ETF (15.69%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.27 billion), Charter Communications, Inc. ($2.66 billion), TC Energy Co. ($2.53 billion), Chesapeake Energy Co. ($1.86 billion), Coinbase Global, Inc. ($1.83 billion), Lucid Group, Inc. ($1.78 billion), T. Rowe Price Group, Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.69 billion), Zoom Video Communications, Inc. ($1.35 billion), and Williams-Sonoma, Inc. ($1.35 billion). View all of the most shorted stocks. What does it mean to sell short Loncar China Biopharma ETF stock? Short selling CHNA is an investing strategy that aims to generate trading profit from Loncar China Biopharma ETF as its price is falling. CHNA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Loncar China Biopharma ETF? A short squeeze for Loncar China Biopharma ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CHNA, which in turn drives the price of the stock up even further. How often is Loncar China Biopharma ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHNA, twice per month. The most recent reporting period available is September, 30 2022. More Short Interest Resources from MarketBeat Related Companies: BIS Short Squeeze JDOC Short Squeeze FTXH Short Squeeze IBBQ Short Squeeze BTEC Short Squeeze BIB Short Squeeze PSCH Short Squeeze BBH Short Squeeze PPH Short Squeeze IBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CHNA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings